Indicators

Latest News about Johnson & Johnson

Recent news which mentions Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9

...

Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival

April 09, 2024

Microsoft, Salesforce woo skeptical CFOs on new generative AI tool spending

March 29, 2024

Jim Cramer names some of the non-tech Nvidia partners to watch

March 19, 2024

Nvidia and Johnson & Johnson to develop new AI applications for surgery

March 18, 2024

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

March 13, 2024

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

February 13, 2024

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

February 08, 2024

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

January 30, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

January 28, 2024

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

January 26, 2024

The U.S. has no federal bereavement leave. What to know about options at work when someone you love dies

January 26, 2024

Treasury yields fall ahead of economic growth numbers

January 25, 2024

Treasury yields pull back as big economic data releases come into view

January 24, 2024

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

January 23, 2024

5 things to know before the stock market opens Tuesday

January 23, 2024

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

January 23, 2024

Treasury yields fractionally higher ahead of key data releases

January 23, 2024

5 things to know before the stock market opens Monday

January 22, 2024

Treasury yields retreat ahead of big week for economic data

January 22, 2024

Cramer's week ahead: Earnings from Procter & Gamble, Tesla, Lockheed Martin

January 19, 2024

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

January 14, 2024

Jim Cramer compares NFL playoffs teams to stock picks

January 12, 2024

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

January 08, 2024

Jim Cramer examines the Dow's best and worst performers of 2023

January 02, 2024

Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive

December 28, 2023

Biden administration's Medicare drug price negotiations will face major tests in 2024

December 28, 2023

10-year Treasury yield falls slightly on shorter trading day

December 22, 2023

10-year Treasury yield falls as investors continue to assess path ahead for rate cuts

December 21, 2023

Treasury yields dip slightly as Fed trajectory remains in focus

December 20, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.